James Terwilliger

Stock Analyst at Northland Capital Markets

(n/a)
# 4,793
Out of 5,090 analysts
5
Total ratings
n/a
Success rate
-50.72%
Average return

Stocks Rated by James Terwilliger

InfuSystem Holdings
Apr 26, 2021
Initiates: Outperform
Price Target: $27
Current: $8.89
Upside: +203.71%
Zynex
Mar 9, 2021
Upgrades: Outperform
Price Target: n/a
Current: $0.89
Upside: -